Biodyne Co., Ltd. (KOSDAQ: 314930)
South Korea
· Delayed Price · Currency is KRW 15,080
-10 (-0.07%)
Jan 21, 2025, 3:00 PM KST
Biodyne Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2015 |
| Other Revenue | - | - | - | -0 | - | - | Upgrade
|
| Revenue | 4,571 | 4,089 | 12,210 | 3,763 | 3,671 | 4,089 | Upgrade
|
| Revenue Growth (YoY) | -61.22% | -66.51% | 224.46% | 2.51% | -10.23% | 8.44% | Upgrade
|
| Cost of Revenue | 2,923 | 3,404 | 2,905 | 3,265 | 3,192 | 2,914 | Upgrade
|
| Gross Profit | 1,648 | 684.27 | 9,305 | 498.56 | 479.17 | 1,175 | Upgrade
|
| Selling, General & Admin | 2,566 | 1,829 | 1,828 | 2,122 | 1,600 | 2,013 | Upgrade
|
| Research & Development | 250.23 | 382.73 | 412.33 | 390.67 | 445.4 | 534.27 | Upgrade
|
| Other Operating Expenses | 20.55 | 27.52 | 10.57 | 75.88 | 80.92 | 49.4 | Upgrade
|
| Operating Expenses | 3,513 | 2,735 | 2,622 | 2,842 | 2,306 | 2,875 | Upgrade
|
| Operating Income | -1,865 | -2,051 | 6,683 | -2,343 | -1,826 | -1,700 | Upgrade
|
| Interest Expense | -0.18 | -0.22 | -0.44 | -215.23 | -589.5 | -378.22 | Upgrade
|
| Interest & Investment Income | 621.64 | 718.05 | 439.18 | 63.82 | 3.23 | 7.94 | Upgrade
|
| Currency Exchange Gain (Loss) | -107.22 | 67.89 | 130.28 | 279.87 | -291.83 | -18.57 | Upgrade
|
| Other Non Operating Income (Expenses) | -37.81 | -60.94 | 63.19 | -8,923 | -2,636 | -533.82 | Upgrade
|
| EBT Excluding Unusual Items | -1,389 | -1,326 | 7,316 | -11,138 | -5,341 | -2,623 | Upgrade
|
| Gain (Loss) on Sale of Investments | 246.66 | 210.85 | 57.77 | - | 257.93 | 151.47 | Upgrade
|
| Gain (Loss) on Sale of Assets | -100.43 | -105.78 | -7.58 | -0.01 | 22.77 | 1.84 | Upgrade
|
| Pretax Income | -1,243 | -1,221 | 7,366 | -11,138 | -5,060 | -2,469 | Upgrade
|
| Income Tax Expense | -236.93 | -229.18 | 1,754 | -281.16 | -605.79 | -442.97 | Upgrade
|
| Net Income | -1,006 | -991.76 | 5,611 | -10,857 | -4,454 | -2,026 | Upgrade
|
| Net Income to Common | -1,006 | -991.76 | 5,611 | -10,857 | -4,454 | -2,026 | Upgrade
|
| Shares Outstanding (Basic) | 29 | 30 | 30 | 6 | 5 | 4 | Upgrade
|
| Shares Outstanding (Diluted) | 29 | 30 | 30 | 6 | 5 | 4 | Upgrade
|
| Shares Change (YoY) | -38.82% | 0.15% | 402.08% | 27.04% | 17.60% | 5140.06% | Upgrade
|
| EPS (Basic) | -34.44 | -33.35 | 189.00 | -1836.00 | -957.00 | -512.00 | Upgrade
|
| EPS (Diluted) | -34.44 | -33.35 | 189.00 | -1836.00 | -957.00 | -512.00 | Upgrade
|
| Free Cash Flow | 1,143 | -264.7 | 1,151 | -1,341 | -759.85 | 963.21 | Upgrade
|
| Free Cash Flow Per Share | 39.14 | -8.90 | 38.76 | -226.74 | -163.25 | 243.36 | Upgrade
|
| Gross Margin | 36.06% | 16.74% | 76.21% | 13.25% | 13.05% | 28.74% | Upgrade
|
| Operating Margin | -40.81% | -50.16% | 54.73% | -62.27% | -49.75% | -41.57% | Upgrade
|
| Profit Margin | -22.00% | -24.26% | 45.96% | -288.50% | -121.34% | -49.56% | Upgrade
|
| Free Cash Flow Margin | 25.00% | -6.47% | 9.42% | -35.63% | -20.70% | 23.55% | Upgrade
|
| EBITDA | -232.55 | -385.37 | 8,241 | -999.01 | -610.68 | -570.2 | Upgrade
|
| EBITDA Margin | -5.09% | -9.43% | 67.49% | -26.55% | -16.64% | -13.94% | Upgrade
|
| D&A For EBITDA | 1,633 | 1,665 | 1,558 | 1,344 | 1,216 | 1,130 | Upgrade
|
| EBIT | -1,865 | -2,051 | 6,683 | -2,343 | -1,826 | -1,700 | Upgrade
|
| EBIT Margin | -40.81% | -50.16% | 54.73% | -62.27% | -49.75% | -41.57% | Upgrade
|
| Effective Tax Rate | - | - | 23.82% | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.